These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 21920117)

  • 21. Eliminating mother to child transmission of HIV-1 and keeping mothers alive: recent progress.
    Govender T; Coovadia H
    J Infect; 2014 Jan; 68 Suppl 1():S57-62. PubMed ID: 24139190
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence for extended age dependent maternal immunity in infected children: mother to child transmission of HIV infection and potential interventions including sulfatides of the human fetal adnexa and complementary or alternative medicines.
    Bhargav H; Huilgol V; Metri K; Sundell IB; Tripathi S; Ramagouda N; Jadhav M; Raghuram N; Ramarao NH; Koka PS
    J Stem Cells; 2012; 7(3):127-53. PubMed ID: 23619381
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevention of mother-to-child transmission of HIV at Maiduguri, Nigeria.
    Chama CM; Audu BM; Kyari O
    J Obstet Gynaecol; 2004 Apr; 24(3):266-9. PubMed ID: 15203622
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Twelve-month follow-up of Six Week Extended Dose Nevirapine randomized controlled trials: differential impact of extended-dose nevirapine on mother-to-child transmission and infant death by maternal CD4 cell count.
    Omer SB;
    AIDS; 2011 Mar; 25(6):767-76. PubMed ID: 21330912
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Birth attendants trained in "Prevention of Mother-To-Child HIV Transmission" provide care in rural Cameroon, Africa.
    Wanyu B; Diom E; Mitchell P; Tih PM; Meyer DJ
    J Midwifery Womens Health; 2007; 52(4):334-41. PubMed ID: 17603955
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A multicenter randomized controlled trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child transmission of human immunodeficiency virus type 1.
    Moodley D; Moodley J; Coovadia H; Gray G; McIntyre J; Hofmyer J; Nikodem C; Hall D; Gigliotti M; Robinson P; Boshoff L; Sullivan JL;
    J Infect Dis; 2003 Mar; 187(5):725-35. PubMed ID: 12599045
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HIV exposed infants: a preliminary report of the Aminu Kano Teaching Hospital experience.
    Mukhtar-Yola M; Gwarzo GD; Galadanci HS; Tukur J; Farouk ZL; Adeleke SI
    Niger Postgrad Med J; 2009 Jun; 16(2):143-8. PubMed ID: 19606195
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human immunodeficiency virus type 1 mother-to-child transmission and prevention: successes and controversies.
    Cavarelli M; Scarlatti G
    J Intern Med; 2011 Dec; 270(6):561-79. PubMed ID: 21929711
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcomes and challenges of scaling up comprehensive PMTCT services in rural Swaziland, Southern Africa.
    Bancheno WM; Mwanyumba F; Mareverwa J
    AIDS Care; 2010 Sep; 22(9):1130-5. PubMed ID: 20824565
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mother-to-child transmission of HIV-1: advances and controversies of the twentieth centuries.
    Scarlatti G
    AIDS Rev; 2004; 6(2):67-78. PubMed ID: 15332429
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Human immunodeficiency virus in newborn of infected mothers: pregnancy, breast feeding and prevention].
    Mor Z; Chemtob D; Pessach N; Nitzan-Kaluski D
    Harefuah; 2006 Sep; 145(9):682-6, 701. PubMed ID: 17078432
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HIV seroprevalence, uptake of interventions to reduce mother-to-child transmission and birth outcomes in greater Kingston, Jamaica.
    Johnson N; Mullings AA; Harvey KM; Alexander G; McDonald D; Smikle MF; Williams E; Palmer P; Whorms S; Figueroa JP; Christie CD
    West Indian Med J; 2004 Oct; 53(5):297-302. PubMed ID: 15675494
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevention in neglected subpopulations: prevention of mother-to-child transmission of HIV infection.
    Mofenson LM
    Clin Infect Dis; 2010 May; 50 Suppl 3():S130-48. PubMed ID: 20397941
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adherence to national guidelines in prevention of mother to child transmission of HIV.
    Musalia AW; Mutungi A; Gachuno O; Kiarie J
    East Afr Med J; 2010 Dec; 87(12):488-94. PubMed ID: 23457858
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Breastmilk Output in a Disadvantaged Community with High HIV Prevalence as Determined by the Deuterium Oxide Dose-to-Mother Technique.
    Mulol H; Coutsoudis A
    Breastfeed Med; 2016 Mar; 11(2):64-9. PubMed ID: 26862660
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elimination of Mother-to-Child Transmission of HIV - Thailand.
    Lolekha R; Boonsuk S; Plipat T; Martin M; Tonputsa C; Punsuwan N; Naiwatanakul T; Chokephaibulkit K; Thaisri H; Phanuphak P; Chaivooth S; Ongwandee S; Baipluthong B; Pengjuntr W; Mekton S
    MMWR Morb Mortal Wkly Rep; 2016 Jun; 65(22):562-6. PubMed ID: 27281244
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low PMTCT coverage / lack of dual therapy 'disgraceful'.
    Bateman C
    S Afr Med J; 2007 Oct; 97(10):906, 908, 910. PubMed ID: 18000569
    [No Abstract]   [Full Text] [Related]  

  • 38. Immunotherapies to prevent mother-to-child transmission of HIV.
    Hicar MD
    Curr HIV Res; 2013 Mar; 11(2):137-43. PubMed ID: 23432489
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A risk measurement tool for targeted HIV prevention measures amongst young pregnant and lactating women in South Africa.
    Ramraj T; Abdelatif N; Chirinda W; Abdullah F; Kindra G; Goga A
    BMC Public Health; 2022 Jun; 22(1):1277. PubMed ID: 35773638
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Global strategies for the prevention of HIV transmission from mothers to infants.
    Karim QA
    Ann N Y Acad Sci; 2000 Nov; 918():36-44. PubMed ID: 11131725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.